Search

Search Constraints

You searched for: Author/Creator Alisi, A.

Search Results

5. Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers. (February 2019)